
No. of Pages: 173 | Report Code: TIPRE00024509 | Category: Life Sciences
No. of Pages: 173 | Report Code: TIPRE00024509 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cell Therapy Bioprocessing Market – By Technology
1.3.2 Cell Therapy Bioprocessing Market – By Cell Type
1.3.3 Cell Therapy Bioprocessing Market – By Indication
1.3.4 Cell Therapy Bioprocessing Market – By End User
1.3.5 Middle East and Africa Cell Therapy Bioprocessing Market – By Country
2. Middle East and Africa Cell Therapy Bioprocessing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Cell Therapy Bioprocessing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Therapy Bioprocessing Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Cell Therapy Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Investments for Cell and Gene Therapy Manufacturing
5.1.2 Growing Approvals for Cell Therapies
5.2 Market Restraints
5.2.1 Challenges Associated with Cell Therapy Bioprocessing
5.3 Market Opportunities
5.3.1 Automated Procedures to Produce Cell Therapies
5.4 Future Trends
5.4.1 Digital Biomanufacturing
5.5 Impact Analysis
6. Cell Therapy Bioprocessing Market – Middle East and Africa Analysis
6.1 Middle East and Africa Cell Therapy Bioprocessing Market Revenue Forecasts and Analysis
7. Middle East and Africa Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Technology
7.1 Overview
7.2 Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)
7.3 Bioreactor
7.3.1 Overview
7.3.2 Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Lyophilization
7.4.1 Overview
7.4.2 Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Electrospinning
7.5.1 Overview
7.5.2 Electrospinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Control flow Centrifugation
7.6.1 Overview
7.6.2 Control flow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Ultrasonic Lysis
7.7.1 Overview
7.7.2 Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Genome Editing Technology
7.8.1 Overview
7.8.2 Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Cell Immortalization Technology
7.9.1 Overview
7.9.2 Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Viral Vector Technology
7.10.1 Overview
7.10.2 Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8. Cell Therapy Bioprocessing Market Analysis – By Cell Type
8.1 Overview
8.2 Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)
8.3 Stem Cell
8.3.1 Overview
8.3.2 Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Immune Cell
8.4.1 Overview
8.4.2 Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Human Embryonic Stem Cell
8.5.1 Overview
8.5.2 Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Pluripotent Stem Cell
8.6.1 Overview
8.6.2 Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
8.7 Hematopoietic Stem Cell
8.7.1 Overview
8.7.2 Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9. Middle East and Africa Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Indication
9.1 Overview
9.2 Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)
9.3 Cardiovascular Disease (CVD)
9.3.1 Overview
9.3.2 Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Wound Healing
9.5.1 Overview
9.5.2 Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopaedic
9.6.1 Overview
9.6.2 Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10. Middle East and Africa Cell Therapy Bioprocessing Market Analysis and Forecasts to 2028– By End User
10.1 Overview
10.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Centres
10.4.1 Overview
10.4.2 Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Regenerative Medicine Centres
10.5.1 Overview
10.5.2 Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
10.6 Academic and Research Institute
10.6.1 Overview
10.6.2 Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
11. Cell Therapy Bioprocessing Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.2 Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
11.1.3 UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.1 UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.3.2 UAE: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.3.3 UAE: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.3.4 UAE: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.3.5 UAE: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
11.1.4 Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.4.1 Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.4.2 Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.4.3 Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.4.4 Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.4.5 Saudi Arabia: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
11.1.5 South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.5.1 South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.5.2 South Africa: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.5.3 South Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.5.4 South Africa: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.5.5 South Africa: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
11.1.6 Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.1 Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
11.1.6.2 Rest of MEA: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)
11.1.6.3 Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)
11.1.6.4 Rest of MEA: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)
11.1.6.5 Rest of MEA: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Middle East and Africa Cell Therapy Bioprocessing Market
12.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Fresenius Kabi AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Asahi Kasei Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERCK KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 THERMO FISHER SCIENTIFIC INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Corning Incorporated
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Cytiva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lonza
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Catalent Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. UAE: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 2. UAE: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 3. UAE: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 4. UAE: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of MEA: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of MEA: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of MEA: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Cell Therapy Bioprocessing Market
LIST OF FIGURES
Figure 1. Cell Therapy Bioprocessing Market Segmentation
Figure 2. Middle East and Africa Cell Therapy Bioprocessing Market Overview
Figure 3. Bioreactor Segment Held Largest Share of Technology in Cell Therapy Bioprocessing Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cell Therapy Bioprocessing Market - Middle East and Africa PEST Analysis
Figure 6. Cell Therapy Bioprocessing Market Impact Analysis of Driver and Restraints
Figure 7. Middle East and Africa Cell Therapy Bioprocessing Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)
Figure 9. Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 10. Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Electrodspinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Control flow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)
Figure 18. Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)
Figure 24. Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)
Figure 30. Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. Middle East & Africa: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)
Figure 35. Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)
Figure 36. UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 41. Growth Strategies Done by the Companies in the Market, (%)